These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 20673201

  • 1. Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement.
    Chang J, Yang W, Fellers T, Kahler KH, Orloff J, Xie J, Tsaneva M, Yu AP, Wu EQ.
    Curr Med Res Opin; 2010 Sep; 26(9):2203-12. PubMed ID: 20673201
    [Abstract] [Full Text] [Related]

  • 2. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Sep; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 3. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE, Scott LJ.
    Am J Cardiovasc Drugs; 2009 Sep; 9(5):309-30. PubMed ID: 19791840
    [Abstract] [Full Text] [Related]

  • 4. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 5. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
    Malesker MA, Hilleman DE.
    Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
    [Abstract] [Full Text] [Related]

  • 6. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I, Saruta T, ADVANCE-Combi Study Group.
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
    Weir MR, Levy D, Crikelair N, Rocha R, Meng X, Glazer R.
    Am J Hypertens; 2007 Jul; 20(7):807-15. PubMed ID: 17586417
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 12. Re: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
    Vivencio B.
    Curr Med Res Opin; 2009 Sep; 25(9):2267-8; author reply 2268-9. PubMed ID: 19630488
    [No Abstract] [Full Text] [Related]

  • 13. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination.
    Kostis JB.
    Am J Ther; 2010 Sep; 17(2):188-96. PubMed ID: 19433970
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 15. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 16. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 17. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J, Ansari A, Mahla G, Handrock R, Klebs S.
    Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.